PRESS   |   CAREERS   |   BLOG    |   CONTACT US   |   ADMIN
 
 
Integrated Medical Professionals
Press
 

Integrated Medical Professionals Among First in the Nation to Treat Advanced Prostate Cancer Patients with PROVENGE



March 17, 2011 - Melville, NY- Integrated Medical Professionals, PLLC, is one of the first facilities in the country to treat advanced prostate cancer patients with PROVENGEģ (sipuleucel-T), an intervention from a new therapeutic class known as autologous cellular immunotherapies. PROVENGE is designed to stimulate a patientís immune system to identify and target prostate cancer. Each patientís dose is formulated individually using their own immune cells.


PROVENGE was approved by the U.S. Food and Drug Administration (FDA) for the treatment of asymptomatic or minimally symptomatic metastatic castrate resistant (hormone refractory) prostate cancer and is manufactured by Dendreon Corporation. It is the first therapeutic drug to show effectiveness in prolonging life for patients who have advanced stage prostate cancer.  Integrated Medical Professionals is providing this alternative for patients in their ongoing commitment to excellence and quality patient care.

Integrated Medical Professionals (IMP) is a multi-specialty practice comprised of community physicians committed to providing the highest level of medical service available.  This cooperative approach has enabled the doctors at IMP to continue to practice in the neighborhoods they have been serving for years while affording them access to technology and services that are just not available to most medical groups.  IMP physicians are on staff at the leading hospitals in the New York Metropolitan Area, are active in clinical and academic research, participate in postgraduate medical education, and lecture nationally and internationally on cutting edge breakthroughs in medicine.